Status:

COMPLETED

PSA Versus STN DBS for TD-PD

Lead Sponsor:

Ruijin Hospital

Collaborating Sponsors:

Suzhou Sceneray Medical Co. , Ltd

Conditions:

Parkinson Disease

Eligibility:

All Genders

18-75 years

Phase:

NA

Brief Summary

The aim of this study is to compare the effectiveness of the deep brain stimulation in the posterior subthalamic area (PSA) versus the subthalamic nucleus (STN) for the treatment of tremor-dominant Pa...

Detailed Description

This is a randomized, double-blinded, crossover trial aiming at comparing the efficacy of PSA and STN DBS in treating tremor-dominant PD. Enrolled patients will undergo bilateral DBS surgery, targetin...

Eligibility Criteria

Inclusion

  • diagnosis of idiopathic Parkinson's disease
  • tremor-dominant subtype in the on-medication condition
  • modified Hoehn-Yahr scale of 2 to 4 in the on-medication condition
  • receiving regular anti-parkinsonian drugs for more than 6 weeks
  • good compliance and written informed consent provided

Exclusion

  • Atypical parkinsonism
  • History of stroke, encephalitis, neuroleptic uses, MRI scan with evidence of significant brain atrophy, lacunar infracts, or other conditions that might interfere with the intracranial surgery
  • Presence of cognitive, or psychiatric or other co-morbidities (e.g., dementia, epilepsy, cranial traumatism, brain tumor, schizophrenia, severe depression or bipolar disorder, personality disorder, etc.) that might interfere with the patient's ability to complete the evaluations or to provide informed consent
  • Presence of anatomical abnormalities in the target region
  • Clinically significant medical history that would increase pre-/post-operative complications
  • Other conditions considered by the investigators that might interfere with the surgery procedure, the follow-ups, and the interpretation of the data

Key Trial Info

Start Date :

June 1 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 26 2025

Estimated Enrollment :

27 Patients enrolled

Trial Details

Trial ID

NCT05382858

Start Date

June 1 2022

End Date

August 26 2025

Last Update

December 2 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

Shanghai, Shanghai Municipality, China, 200025